viral
pneumonia
one
common
maladi
affect
infant
children
throughout
world
world
health
organ
unicef
report
acut
respiratori
infect
continu
lead
caus
mortal
young
children
kill
approxim
million
children
age
develop
countri
case
due
viral
infect
pneumonia
respiratori
diseas
character
inflamm
lung
parenchyma
usual
caus
virus
bacteria
irrit
term
pneumonia
refer
infect
lung
parenchyma
exclud
tissu
airway
bronchi
howev
acut
viral
lower
respiratori
tract
infect
children
thought
affect
epitheli
cell
line
airway
nasopharynx
alveolar
bed
therefor
viral
pneumonia
often
compon
gener
respiratori
tract
infect
syndrom
well
establish
children
younger
year
especi
infant
high
burden
diseas
hospit
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
piv
howev
studi
conduct
last
sever
decad
struggl
defin
precis
quantit
model
incid
diseas
larg
studi
conduct
hospit
thu
lack
known
denomin
patient
risk
studi
also
vari
differ
geograph
locat
studi
type
hospit
age
patient
season
criteria
admiss
sever
diseas
number
type
diagnost
test
perform
rel
new
use
molecular
diagnost
test
increas
abil
diagnos
viru
infect
comparison
data
studi
data
cell
culturebas
studi
problemat
prospect
activ
populationbas
surveil
need
defin
incid
us
center
diseas
control
prevent
sponsor
studi
young
children
hospit
acut
respiratori
ill
octob
septemb
monro
counti
new
york
rochest
area
davidson
counti
tennesse
nashvil
area
elig
children
younger
year
resid
surveil
counti
hospit
febril
acut
respiratori
ill
viral
cultur
polymeras
chain
reaction
identif
virus
nasal
throat
sampl
obtain
surveil
children
provid
populationbas
rate
hospit
rsv
influenza
viru
piv
well
demograph
clinic
risk
factor
assess
viru
enrol
children
rsv
identifi
influenza
piv
respiratori
virus
detect
viru
populationbas
rate
acut
respiratori
ill
hospit
children
younger
year
per
virusposit
hospit
rate
per
children
rsv
piv
influenza
viru
younger
age
particularli
year
black
hispan
raceethn
male
gender
presenc
chronic
underli
ill
associ
higher
hospit
rate
etiolog
agent
caus
viral
pneumonia
well
defin
caus
viral
pneumonia
vari
depend
age
child
set
viru
acquir
season
presenc
medic
environment
risk
factor
although
long
list
virus
report
caus
pneumonia
astut
clinician
narrow
caus
short
list
potenti
agent
use
care
medic
histori
physic
examin
virus
infrequ
caus
present
pneumonia
often
part
gener
present
system
diseas
rubella
cytomegaloviru
cmv
infect
associ
system
diseas
mother
associ
sever
congenit
neonat
diseas
probabl
acquir
transplacent
rout
presum
hematogen
spread
viru
pneumonia
manifest
sign
respiratori
distress
retract
grunt
tachypnea
cyanosi
sometim
requir
immedi
resuscit
mechan
ventil
depress
respir
neonat
viral
pneumonia
present
nonspecif
system
sign
ill
apnea
bradycardia
poor
peripher
perfus
temperatur
instabl
sign
also
frequent
found
bacteri
pneumonia
neonat
period
usual
infant
congenit
cmv
rubella
pneumonia
addit
sign
congenit
infect
petechia
hepatosplenomegali
low
birth
weight
cmv
infect
detect
test
urin
infant
shell
vial
tradit
cell
cultur
herp
simplex
viru
hsv
type
ii
infect
mother
cervix
lead
exposur
infant
labor
birth
infect
mucos
rout
includ
aspir
hsv
capabl
infect
infant
via
ascend
rout
vagin
canal
risk
transmiss
infect
mother
increas
prolong
ruptur
membran
labor
infect
may
acquir
without
prolong
ruptur
membran
passag
birth
canal
transmiss
effici
mother
suffer
primari
infect
oppos
reactiv
presenc
visibl
herpet
lesion
need
viral
pneumonia
jame
e
crow
jr
md
transmiss
infant
herp
simplex
infect
commonli
present
second
week
life
medic
histori
famili
infant
pneumonia
age
consid
risk
factor
physic
examin
seek
manifest
herpet
infect
cytopath
effect
hsv
observ
lung
infant
pneumonia
caus
herp
infect
system
hsv
infect
treat
prolong
cours
intraven
acyclovir
enterovirus
commonli
caus
symptomat
asymptomat
infect
gastrointestin
tract
summer
fall
infect
mother
transmit
enteroviru
infect
infant
birth
infect
caus
sever
system
diseas
includ
pneumonia
viral
infect
acquir
contamin
amniot
fluid
birth
canal
infant
may
affect
clinic
first
hour
birth
nosocomi
transmiss
virus
earli
postpartum
period
occur
surpris
effici
case
common
caus
nosocomi
pneumonia
rsv
occasion
caus
nurseri
outbreak
outbreak
especi
devast
neonat
intens
care
unit
prematur
infant
requir
mechan
ventil
becom
infect
set
infect
usual
transmit
fomit
directli
infect
personnel
via
nasopharyng
secret
common
caus
pneumonia
develop
world
first
week
life
rna
respiratori
virus
especi
rsv
rsv
caus
yearli
winter
epidem
commun
result
hospit
infant
depend
popul
winter
rsv
often
major
caus
hospit
infant
entir
infant
ward
dedic
mani
children
hospit
cohort
infant
annual
epidem
nosocomi
spread
viru
epidem
common
minim
strict
attent
contact
isol
hand
wash
larg
panel
respiratori
virus
capabl
caus
pneumonia
childhood
rsv
human
metapneumoviru
hmpv
piv
type
influenza
viru
type
b
adenovirus
make
major
case
rsv
still
frequent
caus
sever
respiratori
infect
infant
first
week
life
young
children
respons
hospit
year
unit
state
role
rhinovirus
caus
lower
respiratori
tract
ill
pneumonia
much
discuss
rhinoviru
infect
children
common
evid
rhinoviru
infect
found
frequent
children
without
symptom
diseas
therefor
attribut
causal
rhinoviru
case
pneumonia
difficult
virus
nevertheless
rhinoviru
present
significantli
often
case
childhood
pneumonia
expert
believ
rhinoviru
common
etiolog
type
lower
respiratori
tract
ill
children
piv
commonli
associ
laryngotrach
also
caus
pneumonia
less
discret
epidem
caus
rsv
immunocompromis
special
popul
elev
risk
infect
especi
cmv
major
featur
epidemiolog
respiratori
viru
pneumonia
caus
common
agent
determin
unit
state
detail
mostli
seri
semin
longitudin
studi
dc
children
hospit
studi
chapel
hill
pediatr
surveil
studi
vanderbilt
vaccin
clinic
surveil
studi
tecumseh
studi
respiratori
ill
tecumseh
michigan
tucson
children
respiratori
studi
princip
virus
identifi
associ
pneumonia
otherwis
healthi
infant
children
rsv
piv
influenza
virus
studi
use
cell
culturebas
serolog
detect
part
fair
say
studi
optim
cultur
system
rhinovirus
coronavirus
recent
larg
studi
use
databas
method
us
nation
hospit
discharg
survey
data
system
tennesse
medicaid
databas
us
children
confirm
earlier
find
larger
number
ad
detail
risk
factor
sever
diseas
last
sever
year
new
data
emerg
role
newli
identifi
paramyxoviru
hmpv
shown
one
common
caus
associ
lower
respiratori
tract
infect
children
studi
could
address
epidemiolog
viru
discov
children
infect
common
respiratori
virus
first
year
life
minor
suffer
lower
respiratori
tract
diseas
pneumonia
extent
bring
medic
care
studi
identifi
number
risk
factor
sever
diseas
especi
young
age
prematur
preexist
lung
diseas
especi
bronchopulmonari
dysplasia
congenit
heart
diseas
environment
exposur
smoke
wood
fire
heat
daycar
larg
number
sibl
low
socioeconom
statu
birth
near
start
rsv
season
exposur
infect
children
home
nosocomi
exposur
pertin
histor
risk
factor
viral
pneumonia
infect
cell
surround
alveolar
space
alveolar
wall
thicken
alveolar
space
becom
occlud
exud
slough
cell
activ
macrophag
clinic
diseas
distinguish
poor
air
exchang
first
note
poor
oxygen
intak
detect
puls
oximetri
blood
ga
measur
follow
co
retent
physiolog
diseas
reflect
inflammatori
process
result
alveolarcapillari
block
interfer
ga
exchang
result
elev
alveolararteri
po
differ
mani
case
viral
pneumonia
young
children
also
accompani
inflamm
bronchiol
air
trap
contribut
poor
level
ga
exchang
children
compens
respiratori
compromis
better
adult
gener
increas
respiratori
rate
children
show
remark
resili
face
respiratori
compromis
even
though
airway
exhibit
much
higher
intrins
level
resist
unreliev
tachypnea
howev
lead
exhaust
respiratori
failur
histopatholog
mechan
underli
acut
viral
pulmonari
diseas
otherwis
healthi
children
complet
understood
lung
tissu
rare
obtain
histolog
mechan
ventil
medic
intervent
previous
healthi
patient
despit
signific
advanc
understand
basic
virolog
molecular
biolog
virus
base
vitro
studi
rel
littl
known
life
cycl
spread
respiratori
virus
lung
parenchyma
vivo
thought
initi
infect
occur
nasopharynx
inocul
contamin
respiratori
secret
fomit
transmiss
exposur
largeparticl
aerosol
contain
viru
virus
caus
pneumonia
surfac
fusion
protein
mediat
viruscel
fusion
cellcel
fusion
monolay
cell
cultur
virus
caus
cytopath
effect
follow
infect
induc
necrosi
apoptosi
infect
cell
viral
fusion
peptid
virus
caus
multinucl
cell
syncytium
format
cell
monolay
cultur
presum
caus
syncytium
format
vivo
direct
evid
scarc
fact
virus
caus
syncytium
nonpolar
cultur
cell
ie
cell
form
tight
junction
segreg
apic
basolater
plasma
membran
region
often
caus
syncytia
polar
cell
line
primari
cell
cultur
virus
appear
infect
ciliat
noncili
cell
cultur
impair
mucociliari
clearanc
caus
infect
ciliat
cell
probabl
contribut
progress
pneumonia
whether
virus
infect
type
ii
pneumocyt
effici
known
respiratori
virus
caus
abort
round
infect
cultur
macrophag
infect
alveolar
macrophag
may
contribut
inflammatori
diseas
lung
mechan
spread
infect
lower
respiratori
tract
within
day
inocul
unknown
viru
probabl
spread
microaspir
infect
secret
celltocel
spread
viru
rapid
time
cours
spread
vivo
suggest
aspir
infect
secret
result
direct
inocul
lower
respiratori
tract
autopsi
case
fatal
rsv
case
demonstr
presenc
rel
littl
viru
antigen
patholog
chang
fatal
case
patchi
distribut
bronchoalveolar
lavag
tissu
specimen
bone
marrow
transplant
patient
autopsi
evalu
direct
immunofluoresc
immunoperoxidas
stain
reveal
epitheli
cell
macrophag
stain
posit
rsv
protein
electron
microscopi
reveal
occasion
epitheli
cell
cytoplasm
inclus
compos
filament
virion
limit
autopsi
data
pivinfect
influenzainfect
human
summari
popul
cell
primari
target
respiratori
viru
infect
human
probabl
epitheli
origin
fulli
defin
normal
host
hemagglutinin
protein
influenza
viru
mediat
viru
attach
glycoconjug
termin
sialic
acid
caus
fusion
intracellular
membran
low
ph
piv
hemagglutininneuraminidas
glycoprotein
mediat
attach
sialic
acidcontain
host
cell
receptor
rsv
surfac
protein
mediat
attach
rsv
g
glycosyl
glycoprotein
cellular
receptor
fulli
understood
glycosyl
protein
bind
heparan
sulfat
protein
specif
receptor
chemokin
fractalkin
motif
viral
protein
viabil
mutant
rsv
strain
lack
glycosyl
protein
indic
attach
protein
strictli
requir
replic
cell
cultur
rodent
rsv
f
protein
bind
tolllik
receptor
see
studi
hayn
colleagu
heparan
sulfat
interact
cellular
protein
rhoa
whether
serv
princip
protein
receptor
clear
time
associ
common
tolllik
receptor
mutat
sever
rsv
diseas
report
magnitud
charact
inflammatori
respons
airway
appear
highli
regul
epitheli
cellderiv
cytokin
chemokin
attract
activ
specif
subset
leukocyt
associ
airway
inflamm
cytokin
secret
appear
highli
regul
nuclear
factor
transcript
factor
dimer
structur
relat
protein
retain
cytoplasm
associ
inhibitori
protein
upon
variou
cellular
stimul
usual
relat
stress
pathogen
inhibitor
degrad
nuclear
factor
transloc
nucleu
bind
dna
element
induc
transcript
larg
number
gene
especi
associ
immun
respons
nuclear
factorinterleukin
regul
express
cytokin
adhes
molecul
gene
without
increas
transcript
rsv
infect
induc
increas
express
sever
cytokin
includ
transcript
regul
cytokineregul
pathway
appear
contribut
airway
inflamm
pneumonia
immun
cell
also
probabl
play
major
role
pathogenesi
diseas
epitheli
cell
appear
initi
cascad
event
repres
compon
innat
immun
respons
epitheli
cell
secret
solubl
factor
recruit
initi
activ
immun
effector
chemokin
rant
regul
upon
activ
normal
tcell
express
secret
chemoattract
eosinophil
monocyt
cell
basophil
secret
respons
virus
rsv
eventu
adapt
immun
effector
cell
attack
virusinfect
cell
elimin
infect
immun
cytolysi
import
diseas
resolut
come
price
induc
level
immunopatholog
cell
surfac
factor
facilit
home
lymphocyt
lung
tissu
investig
clinic
present
viral
pneumonia
relat
princip
diseas
respiratori
tract
includ
increas
respiratori
rate
supracost
intercost
subcost
retract
infant
show
nasal
flare
grunt
mark
retract
sever
diseas
vital
sign
reveal
fever
half
case
present
fever
higher
much
less
common
bacteri
pneumonia
occur
system
toxic
less
common
bacteri
infect
respiratori
virus
measl
viru
rare
caus
viremia
convent
respiratori
virus
influenza
viru
one
frequent
caus
high
fever
toxic
appear
respiratori
failur
herald
chang
alert
due
hypoxia
co
retent
decreas
respiratori
effort
due
exhaust
requir
immedi
action
physic
examin
reveal
crackl
auscult
gener
promin
inspir
rsv
diseas
infant
commonli
mix
present
bronchiol
pneumonia
case
expiratori
wheez
present
addit
inspiratori
crackl
virus
caus
pneumonia
also
caus
upper
respiratori
tract
infect
therefor
concomit
coryza
common
complic
third
case
otiti
media
nasal
obstruct
caus
purul
nasal
secret
contribut
respiratori
distress
especi
infant
mild
moder
dehydr
common
result
increas
respiratori
insens
loss
poor
oral
fluid
intak
term
pneumonia
lower
respiratori
tract
ill
clinic
anatom
histolog
definit
lower
respiratori
ill
defin
clinic
presenc
crackl
rhonchi
wheez
physic
examin
infiltr
chest
radiograph
anatom
usual
consid
diseas
vocal
cord
pneumonia
inflamm
due
infect
lung
parenchyma
compris
alveoli
interstiti
tissu
possibl
extens
bronchiol
viral
pneumonia
childhood
often
one
compon
lower
respiratori
ill
also
affect
small
larg
conduct
airway
exampl
common
present
sever
rsv
infect
infant
bronchiol
pneumonia
chest
radiograph
use
posteroanterior
view
princip
diagnost
radiolog
test
pneumonia
children
effus
empyema
identifi
chest
radiograph
may
need
comput
tomographi
scan
defin
scope
problem
complic
rare
viral
pneumonia
radiolog
find
chest
radiograph
viral
pneumonia
similar
bronchiol
reactiv
airway
diseas
usual
find
chest
radiograph
hyperaer
promin
lung
mark
due
bronchial
wall
thicken
focal
area
atelectasi
fig
hili
may
somewhat
promin
major
hilar
adenopathi
uncommon
find
commonli
thought
differ
typic
case
bacteri
pneumonia
usual
thought
present
lobar
consolid
true
children
focal
alveolar
pneumonia
laboratori
evid
bacteri
infect
especi
lobar
infiltr
howev
half
children
sole
interstiti
infiltr
chest
radiograph
evid
bacteri
infect
studi
therefor
radiolog
present
interstiti
infiltr
alon
distinguish
bacteri
viral
pneumonia
one
also
differenti
viral
pneumonia
bronchiol
reactiv
airway
diseas
basi
radiolog
find
alon
differenti
base
nonradiolog
factor
age
patient
clinic
histori
chest
radiograph
newborn
viral
pneumonia
usual
show
bilater
diffus
densiti
may
granular
appear
similar
found
hyalin
membran
diseas
infect
congenit
radiograph
chang
may
present
birth
wherea
radiograph
infant
infect
birth
may
normal
initi
rapidli
progress
first
day
life
differenti
diagnosi
nonvir
caus
vari
age
newborn
group
b
streptococcu
infect
hyalin
membran
diseas
common
consider
infant
atyp
organ
chlamydia
trachomati
ureaplasma
urealyticum
must
consid
well
pneumocysti
carinii
children
immunodefici
utero
exposur
human
immunodefici
viru
common
bacteri
caus
pneumonia
bordetella
pertussi
streptococcu
pneumonia
haemophilu
influenza
mostli
nontyp
speci
era
univers
immun
type
b
mycobacteri
infect
includ
tuberculosi
young
children
mycoplasma
pneumonia
pneumonia
mycobacteri
infect
import
older
children
adolesc
atyp
organ
pneumonia
c
trachomati
chlamydia
pneumonia
remain
import
bacteria
pneumonia
b
pertussi
mycobacteri
speci
consider
histoplasma
capsulatum
infect
rel
common
certain
area
unit
state
caus
atyp
pneumonia
cryptococcu
neoforman
infect
also
consider
immunocompromis
patient
mani
publish
studi
address
differenti
bacteri
viral
pneumonia
use
clinic
radiolog
routin
hematolog
test
method
found
suffici
reliabl
differenti
diagnosi
chest
radiograph
find
total
white
blood
cell
count
erythrocyt
sediment
rate
serum
creactiv
protein
use
wide
children
communityacquir
pneumonia
vari
etiolog
discrimin
bacteri
caus
specif
suffici
determin
diagnosi
clinic
practic
lymphocyt
predomin
usual
present
peripher
blood
white
blood
cell
viral
pneumonia
although
featur
also
usual
present
pertussi
atyp
bacteri
infect
bacteri
pneumonia
requir
hospit
averag
caus
higher
fever
viral
pneumonia
often
associ
fever
higher
viral
pneumonia
lobar
segment
round
welldefin
pneumonia
affect
singl
lobe
like
bacteri
etiolog
case
associ
larg
pleural
effus
abscess
bulla
pneumatocel
bedsid
cold
agglutinin
test
may
posit
case
viral
pneumonia
mycoplasm
infect
thu
test
particularli
help
distinguish
etiolog
specif
caus
viral
pneumonia
identifi
sever
method
vari
level
stringenc
cultur
viru
cell
monolay
cultur
consid
gold
standard
virus
identifi
characterist
cytopath
effect
confirm
immunodetect
use
virusspecif
antibodi
fluoresc
detect
cultur
techniqu
requir
high
level
expertis
gener
best
perform
fresh
specimen
secret
obtain
nasopharyng
aspir
nasopharyng
swab
rapid
diagnost
test
rsv
influenza
b
base
immunodetect
viral
protein
nasopharyng
secret
wide
use
posit
predict
valu
appropri
use
epidem
preval
posit
test
expect
high
antigen
detect
test
sensit
enough
determin
hospit
patient
longer
shed
infecti
viru
therefor
neg
test
use
justifi
termin
contact
precaut
patient
viral
pneumonia
increasingli
clinic
detect
virus
perform
molecular
genet
techniqu
revers
transcriptasepolymeras
chain
reaction
follow
hybrid
sequenc
analysi
techniqu
identifi
presenc
viral
nucleic
acid
polymeras
chain
reaction
test
tend
sensit
cell
cultur
period
viral
clearanc
week
infect
clear
long
viral
rna
present
follow
activ
infect
evid
date
show
may
persist
week
month
even
viru
longer
cultur
therefor
posit
polymeras
chain
reactionbas
test
must
use
caution
case
possibl
posit
test
obtain
acut
pneumonia
actual
relat
recent
infect
serolog
help
diagnos
confirm
infect
particularli
clinic
research
set
fourfold
rise
serum
antibodi
viru
preinfect
period
infect
particularli
serolog
test
function
antibodi
use
suggest
specif
diagnosi
practic
use
serolog
test
diagnos
caus
pneumonia
difficult
rise
antibodi
young
children
may
achiev
signific
level
week
pass
evid
presenc
two
virus
case
viral
lower
respiratori
tract
infect
littl
direct
evid
immunocompet
individu
coinfect
character
sever
clinic
cours
infect
singl
agent
bacteri
superinfect
occur
overt
bacteri
lung
diseas
viral
pneumonia
unusu
bacteri
complic
viral
pneumonia
suggest
abrupt
chang
symptom
sever
hour
appear
gener
toxic
possibl
new
radiograph
find
parenchym
consolid
pleural
effus
mark
chang
leukocytosi
eg
cellsmm
white
blood
cell
peripher
blood
suggest
bacteri
process
particularli
sensit
specif
streptococcu
pneumonia
h
influenza
staphylococcu
aureu
common
bacteria
involv
complic
viral
pneumonia
influenza
viru
pneumonia
common
viral
pneumonia
complic
bacteri
infect
recent
vaccin
studi
pneumococc
vaccin
larg
popul
children
show
nineval
bacteri
polysaccharid
vaccin
prevent
third
case
viral
pneumonia
suggest
frequent
interact
bacteria
virus
appar
current
method
clinic
evalu
infant
children
mild
viral
pneumonia
treat
symptomat
outpati
oxygen
requir
grunt
flare
sever
tachypnea
retract
puls
oximetri
indic
oxygen
satur
arteri
blood
ga
measur
indic
depress
po
mm
hg
retent
co
particularli
concern
especi
face
tachypnea
sever
respiratori
distress
hypoxia
dehydr
among
indic
hospit
care
hospit
princip
support
deliveri
supplement
oxygen
intraven
fluid
use
mechan
ventil
case
respiratori
failur
youngest
infant
rsv
pneumonia
may
requir
monitor
risk
apnea
although
apnea
usual
present
near
begin
ill
chest
physiotherapi
mucolyt
may
valu
efficaci
uncertain
viral
pneumonia
specif
viral
diagnosi
made
earli
cours
ill
antivir
medic
avail
licens
drug
influenza
infect
includ
ionchannel
inhibitor
amantidin
rimantidin
neuraminidas
inhibitor
oseltamivir
zanamivir
antivir
compound
work
best
therapi
initi
first
day
infect
particularli
relev
immunosuppress
preexist
cardiopulmonari
diseas
ribavirin
deliv
aerosol
licens
treatment
sever
rsv
infect
recent
studi
question
valu
center
routin
treat
otherwis
healthi
infant
rsv
pneumonia
ribavirin
rsv
intraven
immun
globulin
palivizumab
intramuscular
inject
human
monoclon
antibodi
direct
rsv
fusion
protein
avail
prophylaxi
rsv
diseas
indic
children
chronic
cardiopulmonari
diseas
seriou
risk
factor
clinic
trial
therapi
acut
diseas
use
antibodi
prepar
howev
shown
treatment
effect
hospit
antibiot
therapi
improv
outcom
viral
pneumonia
shown
alter
risk
bacteri
complic
viral
pneumonia
superinfect
indiscrimin
use
antibiot
set
viral
infect
caus
select
antibioticresist
bacteria
secondari
infect
occur
usual
hospit
patient
intens
care
unit
select
infect
bacterium
may
suscept
convent
antibiot
therefor
specif
diagnosi
etiolog
sever
pneumonia
suspect
viral
etiolog
warrant
even
antivir
therapeut
option
anticip
minim
inappropri
antibiot
exposur
mani
common
sequela
bacteri
pneumonia
persist
effus
empyema
abscess
format
pneumatocel
distinctli
uncommon
follow
viral
pneumonia
therefor
prognosi
form
viral
pneumonia
caus
convent
respiratori
virus
excel
otherwis
healthi
children
uncompl
pneumonia
recov
without
sequela
complic
influenza
pneumonia
children
rang
acut
otiti
media
sinus
bacteri
tracheiti
rare
episod
enceph
myositi
myocard
febril
seizur
encephalopathi
rey
syndrom
rsv
diseas
commonli
complic
otiti
media
immunocompromis
children
underli
cardiopulmonari
diseas
neonat
highest
risk
sever
sequela
pulmonari
hypertens
complic
cours
neonat
pneumonia
concomit
pulmonari
hemorrhag
due
vascular
damag
may
follow
pulmonari
interstiti
emphysema
type
ga
leak
occur
especi
mechan
ventil
mortal
high
neonat
viral
pneumonia
especi
prematur
infant
diseas
may
resembl
sever
hyalin
membran
diseas
infant
sever
viral
pneumonia
earli
life
requir
mechan
ventil
treatment
high
concentr
supplement
oxygen
increas
risk
chronic
lung
diseas
case
viral
pneumonia
especi
due
rapidonset
sever
adenoviru
infect
lead
bronchiol
obliteran
hyperluc
lung
syndrom
prognosi
pneumonia
due
uncommon
caus
viral
pneumonia
varicellazost
viru
sarscoronaviru
measl
viru
guard
serum
neutral
antibodi
appear
protect
lower
respiratori
tract
sever
diseas
caus
virus
probabl
result
close
associ
intravascular
space
alveolu
gradient
antibodi
transfer
nasopharynx
quit
steep
higher
level
immunoglobulin
g
igg
antibodi
serum
nasopharynx
level
igg
alveolu
serum
quit
similar
high
level
igg
alveolu
probabl
due
transud
higher
airway
igg
antibodi
transport
neonat
fc
receptor
secretori
iga
uniqu
suit
antivir
activ
respiratori
mucos
surfac
mucos
antibodi
secret
occur
local
polymer
iga
taken
specif
polyimmunoglobulin
receptor
base
polar
epitheli
cell
transcytos
apic
direct
secret
onto
mucosa
antibodi
may
contribut
resolut
acut
primari
infect
lung
iga
igg
rsv
antibodi
present
nasal
secret
infant
earli
infect
decreas
viru
shed
infant
infect
rsv
tempor
associ
detect
rsvspecif
iga
nasal
wash
laboratori
studi
clinic
trial
provid
strong
evid
domin
role
antibodi
protect
reinfect
matern
antibodi
cross
placenta
effici
week
gestat
therefor
prematur
infant
lack
serum
antibodi
protect
viral
pneumonia
confer
term
infant
cellmedi
immun
probabl
play
primari
role
clearanc
establish
respiratori
viru
pneumonia
human
best
evid
support
concept
patient
defect
cellular
immun
recipi
bone
marrow
transplant
patient
cancer
undergo
immunosuppress
chemotherapi
suffer
prolong
viru
shed
frequent
sever
ill
rsv
influenza
viru
piv
type
role
human
cellmedi
immun
effector
protect
diseas
reinfect
viru
challeng
follow
immun
less
clear
howev
macrophag
abund
alveolar
space
lung
vitro
vivo
data
suggest
resid
pulmonari
alveolar
macrophag
popul
activ
suppress
antigenpres
function
lung
dendrit
cell
dc
situ
low
number
dc
high
number
macrophag
note
human
alveolar
compart
suggest
alveolar
compart
may
less
effici
mount
immun
respons
human
alveolar
macrophag
recov
rsv
infect
yield
small
amount
rsv
replic
rsv
alveolar
macrophag
restrict
inocul
human
alveolar
macrophag
live
inactiv
rsv
induc
increas
secret
cytokin
tumor
necrosi
factor
dendrit
cell
wide
distribut
lung
distinguish
morpholog
class
ii
major
histocompat
complex
antigen
express
dc
serv
potent
pulmonari
antigenpres
cell
howev
rel
littl
current
known
cell
respond
specif
respiratori
virus
mucosa
recruit
wave
dc
respiratori
tract
mucosa
appear
featur
acut
cellular
respons
local
challeng
viral
protein
antigen
viru
infect
differenti
dc
lung
home
particular
type
dc
lung
crosstalk
adapt
immun
cell
dc
lung
area
intens
research
virus
commonli
caus
viral
pneumonia
ubiquit
everi
child
becom
infect
first
year
life
common
respiratori
virus
feasibl
avoid
prevent
exposur
infect
therefor
practic
goal
avoid
infect
time
high
risk
prevent
sever
diseas
complic
infect
thorough
hand
wash
use
contact
isol
patient
provid
cohort
critic
prevent
nosocomi
spread
infect
highrisk
individu
hospit
vaccin
atrisk
individu
licens
vaccin
influenza
viru
use
trival
subunit
trival
live
attenu
viru
vaccin
wise
amantidin
rimantidin
use
effect
prophylact
treatment
prevent
symptomat
influenza
diseas
epidem
immedi
follow
exposur
polyclon
rsv
intraven
immun
globulin
monoclon
palivizumab
im
antibodi
prophylact
treatment
use
infant
high
risk
rsv
diseas
treatment
prevent
half
rsv
hospit
treatment
combin
risk
factor
best
predict
suscept
hospit
due
rsv
entir
clear
includ
extrem
prematur
bronchopulmonari
diseas
oxygen
depend
subtl
influenc
import
affect
risk
increment
use
live
attenu
measlesmumpsrubella
vaccin
effect
measl
mump
diseas
varicella
vaccin
prevent
sever
diseas
due
viru
adenoviru
vaccin
use
effect
militari
prevent
epidem
diseas
adult
live
close
quarter
candid
vaccin
develop
test
prevent
viral
pneumonia
caus
rsv
piv
type
hmpv
subunit
live
attenu
rsv
vaccin
test
phase
ii
trial
live
attenu
vaccin
appear
promis
challeng
investig
identifi
gener
attenu
virus
suffici
immunogen
induc
protect
respons
newborn
without
caus
sign
symptom
respiratori
diseas
coldpassag
bovin
strain
piv
type
vaccin
test
extens
human
appear
promis
hmpv
vaccin
candid
gener
test
clinic
trial
date
